Sinocelltech Group Limited (SHA:688520)
38.25
-0.03 (-0.08%)
May 29, 2026, 3:00 PM CST
Sinocelltech Group Market Cap
Sinocelltech Group has a market cap or net worth of 17.99 billion as of May 29, 2026. Its market cap has increased by 9.72% in one year.
Market Cap
17.99B
Enterprise Value
19.55B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
38.25
Market Cap Chart
Since June 22, 2020, Sinocelltech Group's market cap has decreased from 31.81B to 17.99B, a decrease of -43.44%. That is a compound annual growth rate of -9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 17.99B | -6.73% |
| Dec 31, 2025 | 19.29B | 19.54% |
| Dec 31, 2024 | 16.13B | -32.75% |
| Dec 29, 2023 | 23.99B | -11.11% |
| Dec 30, 2022 | 26.99B | 6.06% |
| Dec 31, 2021 | 25.45B | 28.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 26.79B |
| Suzhou Zelgen Biopharmaceuticals | 26.45B |
| Hualan Biological Engineering | 25.11B |
| Xiamen Amoytop Biotech | 22.73B |
| BrightGene Bio-Medical Technology | 22.54B |
| Yili Chuanning Biotechnology | 19.85B |
| Chengdu Olymvax Biopharmaceuticals | 14.26B |
| Anhui Anke Biotechnology (Group) | 13.87B |